<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.1d3" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id>
<journal-title-group>
<journal-title>PLOS ONE</journal-title>
</journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pone.0186356</article-id>
<article-id pub-id-type="publisher-id">PONE-D-17-30523</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject><subj-group><subject>Frameshift mutation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Dermatology</subject><subj-group><subject>Skin diseases</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hyperthermia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Hyperthermia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject><subj-group><subject>Deletion mutation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Mutation</subject><subj-group><subject>Nonsense mutation</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Heredity</subject><subj-group><subject>Genetic mapping</subject><subj-group><subject>Variant genotypes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Diagnostic medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Lower back pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Signs and symptoms</subject><subj-group><subject>Pain</subject><subj-group><subject>Lower back pain</subject></subj-group></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Novel mutations in Darier disease and association to self-reported disease severity</article-title>
<alt-title alt-title-type="running-head">Novel mutations in Darier disease and association to self-reported disease severity</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Leong</surname>
<given-names>Ivone U. S.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Stuckey</surname>
<given-names>Alexander</given-names>
</name>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Ahanian</surname>
<given-names>Tara</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cederlöf</surname>
<given-names>Martin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Investigation</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Dermatology and Venereology Unit, Department of Medicine (Solna), Karolinska Institutet, Stockholm, Sweden</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Division of Gene Technology, School of Biotechnology, Royal Institute of Technology, Science for Life Laboratory, Stockholm, Sweden</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Dermato-Venereology Clinic, Karolinska University Hospital, Stockholm, Sweden</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Toland</surname>
<given-names>Amanda Ewart</given-names>
</name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Ohio State University Wexner Medical Center, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">jakob.wikstrom@ki.se</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>10</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>12</volume>
<issue>10</issue>
<elocation-id>e0186356</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>9</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-year>2017</copyright-year>
<copyright-holder>Leong et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pone.0186356"/>
<abstract>
<p>Darier disease is a rare and severe autosomal dominant skin disease characterised by malodorous keratotic papules in seborrheic areas of the skin. Darier disease affects up to 1 in 30 000 people and is caused by mutations in the <italic>ATP2A2</italic> gene, which encodes to the sarco/endoplasmic reticulum calcium-ATPase isoform 2 that pumps calcium into the endoplasmic reticulum. Although many <italic>ATP2A2</italic> variants have been described, it is not known if genotype correlates with phenotype, which could be important for prognosis and treatment. This is the first study to use whole exome sequencing to screen the <italic>ATP2A2</italic> gene in a cohort of 28 clinically diagnosed Darier disease patients. Twenty-one different disease causing variants were identified and 15 of these were novel. Sixteen of the 21 variants were predicted to be pathogenic using <italic>in silico</italic> prediction programs. There were seven missense, four intronic/splice-sites, three frameshifts, two in-frame deletions, four nonsense and one synonymous mutations. This study also found ten patients who harbour more than one <italic>ATP2A2</italic> variant. The phenotype of the patient cohort was assessed by photography and by patient questionnaires. The genotype-phenotype association was examined for all variants in relation to the patient’s disease severity score, and no correlation could be established.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>Hudfonden</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004359</institution-id>
<institution>Vetenskapsrådet</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100003748</institution-id>
<institution>Svenska Sällskapet för Medicinsk Forskning</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004200</institution-id>
<institution>Stiftelsen Olle Engkvist Byggmästare</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100008738</institution-id>
<institution>Jeanssons Stiftelser</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award006">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100010823</institution-id>
<institution>Tore Nilsons Stiftelse för Medicinsk Forskning</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award007">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100004722</institution-id>
<institution>Stiftelsen Lars Hiertas Minne</institution>
</institution-wrap>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award008">
<funding-source>
<institution>Ostermanns stiftelse</institution>
</funding-source>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-4287-1774</contrib-id>
<name name-style="western">
<surname>Wikstrom</surname>
<given-names>Jakob D.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This study was financially supported by the Swedish Research Council, Swedish Society for Medical Research (SSMF), Olle Engkvist stiftelse, Hudfonden, Tore Nilssons stiftelse, Jeanssons stiftelse, Lars Hiertas stiftelse and OE Ostermanns stiftelse to Jakob D Wikstrom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="3"/>
<table-count count="2"/>
<page-count count="15"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>Darier disease (DD), also known as keratosis follicularis, is a rare and severe autosomal dominant skin disease, estimated to affect 1 in 30 000 to 100 000 people [<xref ref-type="bibr" rid="pone.0186356.ref001">1</xref>, <xref ref-type="bibr" rid="pone.0186356.ref002">2</xref>]. The disease is characterized by keratotic papules and malodorous plaques in seborrheic areas of the skin, which can lead to large, crusted plaques. The disease often emerges during childhood and continues throughout adolescence, and can negatively influence the quality of life [<xref ref-type="bibr" rid="pone.0186356.ref002">2</xref>]. Disease phenotype is highly variable; even when two family members are affected by the same variant, the clinical symptoms may be different [<xref ref-type="bibr" rid="pone.0186356.ref003">3</xref>], which makes genotype-phenotype correlations difficult to determine. UVB irradiation, heat, friction and infections in affected areas can further exacerbate symptoms [<xref ref-type="bibr" rid="pone.0186356.ref004">4</xref>]. Other non-dermatological symptoms of DD include psychiatric conditions, such as intellectual disability and bipolar disease [<xref ref-type="bibr" rid="pone.0186356.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0186356.ref005">5</xref>].</p>
<p>DD is caused by mutations in the <italic>ATP2A2</italic> gene, which encodes the sarco/endoplasmic reticulum calcium (Ca<sup>2+</sup>) -ATPase isoform 2 (SERCA2), a calcium pump in the endoplasmic reticulum (ER) [<xref ref-type="bibr" rid="pone.0186356.ref006">6</xref>]. The <italic>ATP2A2</italic> gene transcript has two isoforms (isoform a and b), and consists of 21 or 20 exons, respectively (<xref ref-type="fig" rid="pone.0186356.g001">Fig 1</xref>). Both SERCA2 isoforms have a phosphorylation (P), nucleotide-binding domain (N) and the actuator domain (A; <xref ref-type="fig" rid="pone.0186356.g001">Fig 1</xref>).</p>
<fig id="pone.0186356.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186356.g001</object-id>
<label>Fig 1</label>
<caption>
<title>The location of all published/reported <italic>ATP2A2</italic> variants (in both isoforms) and variants discovered in the current study associated with Darier disease.</title>
<p><italic>ATP2A2</italic> isoform a consists of 21 exons (top row), which encodes for 10 transmembrane domains (M1 –M10, second row), and it is expressed in cardiomyocytes and slow-tiwtch skeletal muscles. The <italic>ATP2A2</italic> isoform b consists of 20 exons (fourth row), which encodes for 11 transmembrane domains (M1 –M11, third row) and it is expressed in most tissue types [<xref ref-type="bibr" rid="pone.0186356.ref003">3</xref>]. Both isoforms have an actuator domain (A, orange boxes), phosphorylation domain (P, pink boxes), nucleotide binding domain (N, green boxes) and C-terminus (lime green boxes). All genetic variants are listed in either pale yellow (exon with variants discovered in this study) or blue boxes (exon with no variants from this study). Novel genetic variants found in this study are in bold and coloured red. Variants that were discovered in this study but were not novel are in bold only. Intronic variants are in italics. † indicates <italic>ATP2A2</italic> variants with different genetic changes, but resulted in the same amino acid change.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.g001" xlink:type="simple"/>
</fig>
<p>Currently, there are over 270 unique <italic>ATP2A2</italic> mutations associated with DD [<xref ref-type="bibr" rid="pone.0186356.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0186356.ref008">8</xref>], and there are no mutational hotspots. The genetic mutations are predominantly missense/nonsense mutations, followed by deletions, splice-site and insertion mutations. Studies have shown that mutations in the <italic>ATP2A2</italic> gene disrupt normal SERCA2 protein function and leads to impaired/loss of Ca<sup>2+</sup> transport in the ER, which leads to decreased ER Ca<sup>2+</sup> stores [<xref ref-type="bibr" rid="pone.0186356.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0186356.ref014">14</xref>]. Ca<sup>2+</sup> imbalance affects cell-to-cell adhesion in skin and this could explain the DD skin phenotype [<xref ref-type="bibr" rid="pone.0186356.ref015">15</xref>].</p>
<p>To date, there has been no successful genotype-phenotype correlation established in DD. However, this could be important for the diagnosis of disease severity prediction and prognosis of patients. While an epidemiological study of intellectual disability and cognitive ability in Swedish DD patients have been conducted [<xref ref-type="bibr" rid="pone.0186356.ref016">16</xref>], the genetic aspect and the genotype-phenotype association have not been investigated in Sweden. In the current study, the coding sequence of <italic>ATP2A2</italic> of a cohort of 28 clinically diagnosed Swedish DD patients was screened using whole exome sequencing (WES). Patients were asked to score their disease severity and treatment efficacy. The genotype-phenotype association was also examined for all variants in relation to the patient’s disease severity score.</p>
</sec>
<sec id="sec002" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec003">
<title>Patient recruitment</title>
<p>Twenty-eight patients with clinically diagnosed DD were recruited from the Dermato-Venereology clinic of Karolinska University Hospital and other Dermato-Venereology clinics in Sweden, including Uppsala, Linköping and Uddevalla. All patients were Caucasian.</p>
</sec>
<sec id="sec004">
<title>Ethical disclosure</title>
<p>All patients (and/or patients’ guardians) gave written informed consent for genetic testing.</p>
<p>This study was approved by the Stockholm regional ethical board (2017/1098-32).</p>
</sec>
<sec id="sec005">
<title>Patient questionnaire and determination of total body surface area</title>
<p>A questionnaire based on the study conducted by Burge and Wilkinson, (1992) [<xref ref-type="bibr" rid="pone.0186356.ref002">2</xref>] was issued to the patient cohort. The questions included the age of disease onset, the type of medication currently taken, the medication effect (ranked 1–5), disease severity (mild/moderate/severe and ranked from 1–5), general skin symptoms, quality of life, and factors that worsen disease (heat/friction/menstruation/pregnancy/stress/sun). The scores from 1–5 correspond to the following: 1, bad; 2, acceptable; 3, good; 4, very good; and 5, excellent [<xref ref-type="bibr" rid="pone.0186356.ref017">17</xref>].</p>
<p>The total body surface area (TBSA) affected by disease was assessed for each patient using photographs taken at the time when blood was drawn for WES. The TBSA was based on the rule of nines, which is a method used to quantify the area of affected skin in burns victims [<xref ref-type="bibr" rid="pone.0186356.ref018">18</xref>]. The assessment was blinded in that the genotype was unknown to the examiner.</p>
</sec>
<sec id="sec006">
<title>Whole exome sequencing and bioinformatics analysis</title>
<p>The Centre of Genomics and Transcriptomics (CeGAT, Tubingen, Germany) performed the WES. The exome was enriched by the Agilent SureSelectXT Human All Exon V6 (Agilent, CA, USA). The enriched libraries were sequenced using the Illumina HiSeq (Illumina, CA, USA) high-throughput sequencing platform with a read-length of 2 x 100 bp. Raw sequencing reads were processed according to the CeGAT bioinformatics streamlined process to generate a list of <italic>ATP2A2</italic> gene variants.</p>
</sec>
<sec id="sec007">
<title>Bidirectional Sanger-based sequencing confirmation</title>
<p>All reported <italic>ATP2A2</italic> variants were confirmed by bi-directional Sanger-based sequencing. All <italic>ATP2A2</italic> PCR primers were previously published by Ringpfeil et al., (2001) [<xref ref-type="bibr" rid="pone.0186356.ref019">19</xref>], with the addition of M13 forward or reverse sequences on the 5’ end. PCR was performed as previously described [<xref ref-type="bibr" rid="pone.0186356.ref020">20</xref>]. PCR products were electrophoresed in 1% UltraPure<sup>™</sup> Agarose (Thermo Fisher Scientific, MA, USA) with GelRed<sup>™</sup> (Biotium, CA, USA) incorporated into the gel.</p>
<p>Subsequent to gel electrophoresis confirmation, the PCR products were submitted to KI Gene (Centre for Molecular Medicine, Karolinska University Hospital Solna, Sweden) for bi-directional Sanger-based sequencing. The sequence analysis was performed using Geneious software (version 7.1.9) [<xref ref-type="bibr" rid="pone.0186356.ref021">21</xref>].</p>
</sec>
<sec id="sec008">
<title><italic>ATP2A2</italic> variant analysis</title>
<p>The pathogenicity of missense and intronic/splice-site variants were assessed using <italic>in silico</italic> prediction programs. Missense variants were assessed with PolyPhen-2 [<xref ref-type="bibr" rid="pone.0186356.ref022">22</xref>], SIFT [<xref ref-type="bibr" rid="pone.0186356.ref023">23</xref>] and SNPs&amp;GO [<xref ref-type="bibr" rid="pone.0186356.ref024">24</xref>], and the splice-site variants were assessed with ASSP [<xref ref-type="bibr" rid="pone.0186356.ref025">25</xref>] and HSF [<xref ref-type="bibr" rid="pone.0186356.ref026">26</xref>]. A mutation is categorised as benign or pathogenic when the majority of scores from the prediction programs are concordant [<xref ref-type="bibr" rid="pone.0186356.ref027">27</xref>]. For nonsense and frameshift mutations, it was assumed that the variants would be deleterious to correct protein function. The variants were not categorised solely based on the predicted outcomes; dbSNP database (build 149) [<xref ref-type="bibr" rid="pone.0186356.ref028">28</xref>], Exome Aggregation Consortium (ExAC) database [<xref ref-type="bibr" rid="pone.0186356.ref029">29</xref>], and Exome Sequencing Project (ESP) [<xref ref-type="bibr" rid="pone.0186356.ref030">30</xref>] database were also used to determine if variants were rare polymorphisms.</p>
</sec>
</sec>
<sec id="sec009" sec-type="results">
<title>Results</title>
<p>Twenty-eight patients (19 females and nine males) with clinically diagnosed DD were screened for <italic>ATP2A2</italic> variants. Nine were family members from four different families (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). Fourteen of the 28 patients have a family history of DD, nine could be sporadic cases and two patients were adopted (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). Twenty-one different variants were found, and 15 were novel variants that have not been previously reported in the literature or any databases (i.e. dbSNP [<xref ref-type="bibr" rid="pone.0186356.ref028">28</xref>] or LOVD database [<xref ref-type="bibr" rid="pone.0186356.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0186356.ref008">8</xref>]; <xref ref-type="table" rid="pone.0186356.t001">Table 1</xref> and <xref ref-type="fig" rid="pone.0186356.g001">Fig 1</xref>).</p>
<table-wrap id="pone.0186356.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186356.t001</object-id>
<label>Table 1</label> <caption><title>List of <italic>ATP2A2</italic> mutations found in DD patients described in this study.</title></caption>
<alternatives>
<graphic id="pone.0186356.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">ID</th>
<th align="left">Age of testing</th>
<th align="left">Age of onset</th>
<th align="left">Sex</th>
<th align="left">Family history of disease</th>
<th align="left">Nucleotide change</th>
<th align="left">Amino acid change</th>
<th align="left">Zygosity</th>
<th align="left">Exon</th>
<th align="left">Domain</th>
<th align="left">Mutation type</th>
<th align="left">dbSNP</th>
<th align="left">ExAC/ESP</th>
<th align="left">Predicted outcome</th>
<th align="left">Reported</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">1</td>
<td align="left">43</td>
<td align="left"/>
<td align="left">F</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">2</td>
<td align="left">27</td>
<td align="left">11</td>
<td align="left">M</td>
<td align="left">Yes</td>
<td align="left">c.2840T&gt;G</td>
<td align="left">p.L947R</td>
<td align="left">Het</td>
<td align="left">19</td>
<td align="left">M 9</td>
<td align="left">Missense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">3</td>
<td align="left">50</td>
<td align="left">19</td>
<td align="left">F</td>
<td align="left">No</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">4</td>
<td align="left">51</td>
<td align="left">14</td>
<td align="left">M</td>
<td align="left">No</td>
<td align="left">c.1762-3_1767del</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">14</td>
<td align="left">N</td>
<td align="left">Essential splice-site</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">5<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">47</td>
<td align="left">19</td>
<td align="left">M</td>
<td align="left">No</td>
<td align="left">c.2172G&gt;A</td>
<td align="left">p.A724=</td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">P</td>
<td align="left">Synonymous</td>
<td align="left">rs56243033</td>
<td align="left">0.055/0.05</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref031">31</xref>]</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">56</td>
<td align="left">3.5</td>
<td align="left">M</td>
<td align="left">Yes</td>
<td align="left">c.2840T&gt;G</td>
<td align="left">p.L947R</td>
<td align="left">Het</td>
<td align="left">19</td>
<td align="left">M 9</td>
<td align="left">Missense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">7<xref ref-type="table-fn" rid="t001fn001"><sup>†</sup></xref></td>
<td align="left">68</td>
<td align="left">20</td>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.1675C&gt;T</td>
<td align="left">p.R559<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">13</td>
<td align="left">N</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">8</td>
<td align="left" rowspan="2">67</td>
<td align="left" rowspan="2">64</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">Adopted</td>
<td align="left">c.220-18G&gt;A</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">i3</td>
<td align="left">M 1</td>
<td align="left">Intronic</td>
<td align="left">rs35235621</td>
<td align="left">0.015/0.018</td>
<td align="left">Benign</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2843_2844delAT</td>
<td align="left">p.Y948Cfs<xref ref-type="table-fn" rid="t001fn001">*</xref>33</td>
<td align="left">Het</td>
<td align="left">19</td>
<td align="left">M 9</td>
<td align="left">Frameshift</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">9<xref ref-type="table-fn" rid="t001fn001"><sup>†</sup></xref></td>
<td align="left" rowspan="2">30</td>
<td align="left" rowspan="2"/>
<td align="left" rowspan="2">M</td>
<td align="left" rowspan="2"/>
<td align="left">c.1675C&gt;T</td>
<td align="left">p.R559<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">13</td>
<td align="left">N</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
<td align="left">p.A724=</td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">P</td>
<td align="left">Synonymous</td>
<td align="left">rs56243033</td>
<td align="left">0.055/0.05</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref031">31</xref>]</td>
</tr>
<tr>
<td align="left" rowspan="2">10</td>
<td align="left" rowspan="2">44</td>
<td align="left" rowspan="2">14</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">Adopted</td>
<td align="left">c.1216C&gt;T</td>
<td align="left">p.Q406<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">10</td>
<td align="left">N</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
<td align="left">p.A724=</td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">P</td>
<td align="left">Synonymous</td>
<td align="left">rs56243033</td>
<td align="left">0.055/0.05</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref031">31</xref>]</td>
</tr>
<tr>
<td align="left">11</td>
<td align="left">60</td>
<td align="left">12</td>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.2608-2A&gt;C</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">i17</td>
<td align="left"/>
<td align="left">Essential splice-site</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">12</td>
<td align="left">64</td>
<td align="left"/>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.2608-2A&gt;C</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">i17</td>
<td align="left"/>
<td align="left">Essential splice-site</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">13</td>
<td align="left" rowspan="2">78</td>
<td align="left" rowspan="2">15</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">Yes</td>
<td align="left">c.803G&gt;T</td>
<td align="left">p.C268F</td>
<td align="left">Het</td>
<td align="left">8</td>
<td align="left">M 3</td>
<td align="left">Missense</td>
<td align="left">rs121912733</td>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref003">3</xref>]</td>
</tr>
<tr>
<td align="left">c.1386_1390delTTCTA</td>
<td align="left">p.S463Nfs<xref ref-type="table-fn" rid="t001fn001">*</xref>12</td>
<td align="left">Het</td>
<td align="left">11</td>
<td align="left">N</td>
<td align="left">Frameshift</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">14</td>
<td align="left">67</td>
<td align="left">16</td>
<td align="left">M</td>
<td align="left">Yes</td>
<td align="left">c.922_945del</td>
<td align="left">p.P308_I315del</td>
<td align="left">Het</td>
<td align="left">8</td>
<td align="left">M 4</td>
<td align="left">Deletion (in-frame)</td>
<td align="left"/>
<td align="left"/>
<td align="left">Likely pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">15<xref ref-type="table-fn" rid="t001fn001">**</xref></td>
<td align="left">65</td>
<td align="left">22.5</td>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.79delG</td>
<td align="left">p.E27Nfs<xref ref-type="table-fn" rid="t001fn001">*</xref>27</td>
<td align="left">Het</td>
<td align="left">1</td>
<td align="left">A</td>
<td align="left">Frameshift</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">16<xref ref-type="table-fn" rid="t001fn001">**</xref></td>
<td align="left">44</td>
<td align="left">14</td>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.79delG</td>
<td align="left">p.E27Nfs<xref ref-type="table-fn" rid="t001fn001">*</xref>27</td>
<td align="left">Het</td>
<td align="left">1</td>
<td align="left">A</td>
<td align="left">Frameshift</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">17</td>
<td align="left">60</td>
<td align="left">20</td>
<td align="left">F</td>
<td align="left">No</td>
<td align="left">c.2945C&gt;T</td>
<td align="left">p.T982M</td>
<td align="left">Het</td>
<td align="left">20</td>
<td align="left">M 10</td>
<td align="left">Missense</td>
<td align="left">rs149024535</td>
<td align="left">0.0017/0.0003</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref032">32</xref>]</td>
</tr>
<tr>
<td align="left">18</td>
<td align="left">81</td>
<td align="left">Unsure</td>
<td align="left">F</td>
<td align="left">No</td>
<td align="left">c.2294C&gt;T</td>
<td align="left">p.S765L</td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">M 5</td>
<td align="left">Missense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">19</td>
<td align="left" rowspan="2">61</td>
<td align="left" rowspan="2">16</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">No</td>
<td align="left">c.220-18G&gt;A</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">i3</td>
<td align="left">M 1</td>
<td align="left">Intronic</td>
<td align="left">rs35235621</td>
<td align="left">0.015/0.018</td>
<td align="left">Benign</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.1825_1827delTCC</td>
<td align="left">p.S609del</td>
<td align="left">Het</td>
<td align="left">14</td>
<td align="left">P</td>
<td align="left">Deletion (in-frame)</td>
<td align="left">rs767885880</td>
<td align="left">0.000008</td>
<td align="left">Likely pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">20</td>
<td align="left" rowspan="2">49</td>
<td align="left" rowspan="2">13</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">No</td>
<td align="left">c.545-12C&gt;G</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">i6</td>
<td align="left">A</td>
<td align="left">Intronic</td>
<td align="left"/>
<td align="left"/>
<td align="left">Benign</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2797G&gt;A</td>
<td align="left">p.V933M</td>
<td align="left">Het</td>
<td align="left">19</td>
<td align="left">M 9</td>
<td align="left">Missense</td>
<td align="left">rs372102705</td>
<td align="left">0.0001/0.00008</td>
<td align="left">Benign</td>
<td align="left"/>
</tr>
<tr>
<td align="left">21</td>
<td align="left">55</td>
<td align="left">14</td>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.2385T&gt;G</td>
<td align="left">p.N795K</td>
<td align="left">Het</td>
<td align="left">16</td>
<td align="left">M 6</td>
<td align="left">Missense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">22<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left" rowspan="2">48</td>
<td align="left" rowspan="2">20</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">Yes</td>
<td align="left">c.1720G&gt;T</td>
<td align="left">p.E574<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">13</td>
<td align="left">N</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
<td align="left">p.A724=</td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">P</td>
<td align="left">Synonymous</td>
<td align="left">rs56243033</td>
<td align="left">0.055/0.05</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref031">31</xref>]</td>
</tr>
<tr>
<td align="left" rowspan="2">23<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left" rowspan="2">79</td>
<td align="left" rowspan="2">23</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">Yes</td>
<td align="left">c.1720G&gt;T</td>
<td align="left">p.E574<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">13</td>
<td align="left">N</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
<td align="left">p.A724=</td>
<td align="left">Hom</td>
<td align="left">15</td>
<td align="left">P</td>
<td align="left">Synonymous</td>
<td align="left">rs56243033</td>
<td align="left">0.055/0.05</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref031">31</xref>]</td>
</tr>
<tr>
<td align="left" rowspan="2">24</td>
<td align="left" rowspan="2">33</td>
<td align="left" rowspan="2">22</td>
<td align="left" rowspan="2">F</td>
<td align="left" rowspan="2">Yes</td>
<td align="left">c.116A&gt;G</td>
<td align="left">p.N39S</td>
<td align="left">Het</td>
<td align="left">1</td>
<td align="left">A</td>
<td align="left">Missense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.220-18G&gt;A</td>
<td align="left"/>
<td align="left">Het</td>
<td align="left">i3</td>
<td align="left">M 1</td>
<td align="left">Intronic</td>
<td align="left">rs35235621</td>
<td align="left">0.015/0.018</td>
<td align="left">Benign</td>
<td align="left"/>
</tr>
<tr>
<td align="left">25</td>
<td align="left">56</td>
<td align="left">15</td>
<td align="left">M</td>
<td align="left">No</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">26<xref ref-type="table-fn" rid="t001fn001"><sup>††</sup></xref></td>
<td align="left">66</td>
<td align="left">16</td>
<td align="left">F</td>
<td align="left">Yes</td>
<td align="left">c.2272C&gt;T</td>
<td align="left">p.Q758<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">M 5</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left" rowspan="2">27<xref ref-type="table-fn" rid="t001fn001"><sup>††</sup></xref></td>
<td align="left" rowspan="2">32</td>
<td align="left" rowspan="2"/>
<td align="left" rowspan="2">M</td>
<td align="left" rowspan="2"/>
<td align="left">c.2272C&gt;T</td>
<td align="left">p.Q758<xref ref-type="table-fn" rid="t001fn001">*</xref></td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">M 5</td>
<td align="left">Nonsense</td>
<td align="left"/>
<td align="left"/>
<td align="left">Pathogenic</td>
<td align="left"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
<td align="left">p.A724=</td>
<td align="left">Het</td>
<td align="left">15</td>
<td align="left">P</td>
<td align="left">Synonymous</td>
<td align="left">rs56243033</td>
<td align="left">0.055</td>
<td align="left">Benign</td>
<td align="left">[<xref ref-type="bibr" rid="pone.0186356.ref031">31</xref>]</td>
</tr>
<tr>
<td align="left">28</td>
<td align="left">61</td>
<td align="left">20</td>
<td align="left">M</td>
<td align="left">No</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>*<sup>, †,</sup> **<sup>, ††</sup> represent patients that are related. Rows that are blank are patients who did not harbour an <italic>ATP2A2</italic> variant. F, female; M, male; Het, heterozygous; Hom, homozygous; i<italic>x</italic>, intron <italic>x</italic>; M<italic>x</italic>, transmembrane domain <italic>x</italic>; A, actuator domain; P, phosphorylation domain; N, nucleotide binding domain.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Four patients (patients 1, 3, 25 and 28) did not have any variants in the <italic>ATP2A2</italic> gene despite clinically diagnosed with DD, and two patients had benign <italic>ATP2A2</italic> variants (patient 5 and 17, <xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). Ten patients had two different <italic>ATP2A2</italic> variants, and for most of these patients, one variant was benign and the other predicted to be pathogenic (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). One patient had two benign variants (Patient 20), and one patient had two pathogenic variants (Patient 13; <xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). The read-depth of each of the <italic>ATP2A2</italic> exons for each patient sample is shown in <xref ref-type="supplementary-material" rid="pone.0186356.s001">S1 Fig</xref>.</p>
<sec id="sec010">
<title>Spectrum of variants</title>
<p>Sixteen of 21 variants were predicted to be pathogenic (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref> and <xref ref-type="supplementary-material" rid="pone.0186356.s003">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0186356.s004">S2</xref> Tables). There are five missense mutations; two in-frame deletions; two essential splice-site mutations; three frameshift mutations and four nonsense mutations (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). The benign variants consisted of two intronic mutations, two missense mutations, and one synonymous mutation (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>). All variants are scattered throughout <italic>ATP2A2</italic> and these are shown in <xref ref-type="fig" rid="pone.0186356.g001">Fig 1</xref> in relation to all previously reported <italic>ATP2A2</italic> variants [<xref ref-type="bibr" rid="pone.0186356.ref007">7</xref>, <xref ref-type="bibr" rid="pone.0186356.ref008">8</xref>]. Eleven variants are located in the transmembrane domains (M1, M3, M4, M5–7, M9 and M10), three in the actuator (A) domain, five in the nucleotide binding (N) domain, and two in the phosphorylation (P) domain (<xref ref-type="table" rid="pone.0186356.t001">Table 1</xref>).</p>
</sec>
<sec id="sec011">
<title>Phenotypic analysis</title>
<p>To investigate whether there is a genotype-phenotype correlation, patients were asked a series of questions regarding their disease state. Twenty-five of the 28 patients (89%) responded, 18 women and seven men. Four of these patients did not harbour an <italic>ATP2A2</italic> genetic variant.</p>
<p>The age of onset for the majority of patients was below 20 years of age (76%; <xref ref-type="fig" rid="pone.0186356.g002">Fig 2A</xref>). The total body surface area (TBSA) affected by disease was also variable, with the majority of patients having disease on 1–20% of their bodies (84%; <xref ref-type="fig" rid="pone.0186356.g002">Fig 2B</xref>). The most commonly affected skin areas were the skin folds (56%) and trunk of the body (52%; <xref ref-type="table" rid="pone.0186356.t002">Table 2</xref>). Itchy skin (92%), heat, sun and stress (72–84%) were the most common exacerbating factor for many patients (<xref ref-type="fig" rid="pone.0186356.g002">Fig 2C and 2D</xref>). More than half of the patients who responded to the questionnaire (60%) were negatively affected by DD and found that it affected their life quality (<xref ref-type="table" rid="pone.0186356.t002">Table 2</xref>). Most patients were treated systemically with either acitretin or isotretionin (68%), and some were treated topically (24%; <xref ref-type="fig" rid="pone.0186356.g002">Fig 2E</xref>).</p>
<fig id="pone.0186356.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186356.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Clinical characteristics of the cohort.</title>
<p>Age of onset (A), total body surface area affected (B), skin symptoms (C), worsening factors (D) and medication type (E) in the patient cohort.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.g002" xlink:type="simple"/>
</fig>
<table-wrap id="pone.0186356.t002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186356.t002</object-id>
<label>Table 2</label> <caption><title>Patient clinical characteristics.</title></caption>
<alternatives>
<graphic id="pone.0186356.t002g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.t002" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">ID</th>
<th align="left">Sex</th>
<th align="left">Nucleotide change</th>
<th align="left">Type of medication</th>
<th align="left">TBSA (%)</th>
<th align="left">Affected skin areas</th>
<th align="left">Reduction in quality of life?</th>
<th align="left">General skin symptoms</th>
<th align="left">Factors that worsens disease</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left">1</td>
<td align="left">F</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center"/>
<td align="center"/>
<td align="left"/>
</tr>
<tr>
<td align="left">2</td>
<td align="left">M</td>
<td align="left">c.2840T&gt;G</td>
<td align="left">Moisturizer</td>
<td align="left">18</td>
<td align="left">Face, scalp, trunk, only mildly in skin folds, mild elsewhere</td>
<td align="center">Yes</td>
<td align="center">Itch</td>
<td align="left">Friction, heat, friction, stress, sun</td>
</tr>
<tr>
<td align="left">3</td>
<td align="left">F</td>
<td align="left"/>
<td align="left">Topical</td>
<td align="left"/>
<td align="left">Back, shoulders, trunk</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Heat, sun</td>
</tr>
<tr>
<td align="left">4</td>
<td align="left">M</td>
<td align="left">c.1762-3_1767del</td>
<td align="left">Acitretin</td>
<td align="left">4</td>
<td align="left">Face, scalp, trunk, only mildly in skin folds</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Heat, stress, sun</td>
</tr>
<tr>
<td align="left">5<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
<td align="left">M</td>
<td align="left">c.2172G&gt;A</td>
<td align="left">Topical</td>
<td align="left">1</td>
<td align="left">Trunk, shoulders, back</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Heat, stress, sun</td>
</tr>
<tr>
<td align="left">6</td>
<td align="left">M</td>
<td align="left">c.2840T&gt;G</td>
<td align="left">Acitretin</td>
<td align="left">10</td>
<td align="left">Back, shoulders, trunk</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Stress</td>
</tr>
<tr>
<td align="left">7<xref ref-type="table-fn" rid="t002fn001"><sup>†</sup></xref></td>
<td align="left">F</td>
<td align="left">c.1675C&gt;T</td>
<td align="left">Acitretin</td>
<td align="left">1</td>
<td align="left">Small defined area only on one side</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Heat, sun</td>
</tr>
<tr>
<td align="left" rowspan="2">8</td>
<td align="left" rowspan="2">F</td>
<td align="left">c.220-18G&gt;A</td>
<td align="left" rowspan="2">Acitretin</td>
<td align="left" rowspan="2">5</td>
<td align="left" rowspan="2">Trunk</td>
<td align="center" rowspan="2">No</td>
<td align="center" rowspan="2">NA</td>
<td align="left" rowspan="2">Sun</td>
</tr>
<tr>
<td align="left">c.2843_2844delAT</td>
</tr>
<tr>
<td align="left" rowspan="2">9<xref ref-type="table-fn" rid="t002fn001"><sup>†</sup></xref></td>
<td align="left" rowspan="2">M</td>
<td align="left">c.1675C&gt;T</td>
<td align="left" rowspan="2"/>
<td align="left" rowspan="2"/>
<td align="left" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="left" rowspan="2"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
</tr>
<tr>
<td align="left" rowspan="2">10</td>
<td align="left" rowspan="2">F</td>
<td align="left">c.1216C&gt;T</td>
<td align="left" rowspan="2">Isotretinoin</td>
<td align="left" rowspan="2">6</td>
<td align="left" rowspan="2">Trunk</td>
<td align="center" rowspan="2">Yes</td>
<td align="center" rowspan="2">Itch</td>
<td align="left" rowspan="2">Heat, sun</td>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
</tr>
<tr>
<td align="left">11</td>
<td align="left">F</td>
<td align="left">c.2608-2A&gt;C</td>
<td align="left">Acitretin</td>
<td align="left">17</td>
<td align="left">Hands, feet</td>
<td align="center">Yes</td>
<td align="center">Itch, pain</td>
<td align="left">Friction, heat, stress, sun</td>
</tr>
<tr>
<td align="left">12</td>
<td align="left">F</td>
<td align="left">c.2608-2A&gt;C</td>
<td align="left">Acitretin</td>
<td align="left">12</td>
<td align="left">Face, folds, trunk</td>
<td align="center">Yes</td>
<td align="center">Itch</td>
<td align="left">Friction, heat, stress, sun</td>
</tr>
<tr>
<td align="left" rowspan="2">13</td>
<td align="left" rowspan="2">F</td>
<td align="left">c.803G&gt;T</td>
<td align="left" rowspan="2">Acitretin</td>
<td align="left" rowspan="2">18</td>
<td align="left" rowspan="2">Face, hands, scalp</td>
<td align="center" rowspan="2">Yes</td>
<td align="center" rowspan="2">Odour, pain</td>
<td align="left" rowspan="2">Friction, heat, menstruation, pregnancy, stress, sun</td>
</tr>
<tr>
<td align="left">c.1386_1390delTTCTA</td>
</tr>
<tr>
<td align="left">14</td>
<td align="left">M</td>
<td align="left">c.922_945del</td>
<td align="left">Acitretin</td>
<td align="left">14</td>
<td align="left">Folds, only mild elsewhere</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Heat, stress, sun</td>
</tr>
<tr>
<td align="left">15<xref ref-type="table-fn" rid="t002fn001">**</xref></td>
<td align="left">F</td>
<td align="left">c.79delG</td>
<td align="left">None</td>
<td align="left">2</td>
<td align="left">Folds, only mild elsewhere</td>
<td align="center">Yes</td>
<td align="center">Itch, odour, pain</td>
<td align="left">Friction, heat, stress, sun</td>
</tr>
<tr>
<td align="left">16<xref ref-type="table-fn" rid="t002fn001">**</xref></td>
<td align="left">F</td>
<td align="left">c.79delG</td>
<td align="left">Acitretin</td>
<td align="left">12</td>
<td align="left">Entire body</td>
<td align="center">Yes</td>
<td align="center">Itch, odour, pain</td>
<td align="left">Friction, heat, stress</td>
</tr>
<tr>
<td align="left">17</td>
<td align="left">F</td>
<td align="left">c.2945C&gt;T</td>
<td align="left">Laser</td>
<td align="left">1</td>
<td align="left">Face, scalp, trunk, only mildly in skin folds</td>
<td align="center">Yes</td>
<td align="center">Itch, odour</td>
<td align="left">Heat</td>
</tr>
<tr>
<td align="left">18</td>
<td align="left">F</td>
<td align="left">c.2294C&gt;T</td>
<td align="left">Acitretin</td>
<td align="left">12</td>
<td align="left">Lower back, knee folds, waist</td>
<td align="center">No</td>
<td align="center">Itch</td>
<td align="left">Heat</td>
</tr>
<tr>
<td align="left" rowspan="2">19</td>
<td align="left" rowspan="2">F</td>
<td align="left">c.220-18G&gt;A</td>
<td align="left" rowspan="2">Acitretin</td>
<td align="left" rowspan="2">6</td>
<td align="left" rowspan="2">Back, hands, feet, thighs, trunk</td>
<td align="center" rowspan="2">Yes</td>
<td align="center" rowspan="2">Itch, odour, pain</td>
<td align="left" rowspan="2">Heat, stress, sun</td>
</tr>
<tr>
<td align="left">c.1825_1827delTCC</td>
</tr>
<tr>
<td align="left" rowspan="2">20</td>
<td align="left" rowspan="2">F</td>
<td align="left">c.545-12C&gt;G</td>
<td align="left" rowspan="2">Acitretin</td>
<td align="left" rowspan="2">10</td>
<td align="left" rowspan="2">Face, scalp, trunk, only mildly in skin folds</td>
<td align="center" rowspan="2">Yes</td>
<td align="center" rowspan="2">Itch, pain</td>
<td align="left" rowspan="2">Friction, heat, menstruation, stress</td>
</tr>
<tr>
<td align="left">c.2797G&gt;A</td>
</tr>
<tr>
<td align="left">21</td>
<td align="left">F</td>
<td align="left">c.2385T&gt;G</td>
<td align="left">Acitretin</td>
<td align="left">22</td>
<td align="left">Entire body, also pharynx</td>
<td align="center">Yes</td>
<td align="center">Itch, odour, pain</td>
<td align="left">Friction, heat, stress, sun</td>
</tr>
<tr>
<td align="left" rowspan="2">22<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
<td align="left" rowspan="2">F</td>
<td align="left">c.1720G&gt;T</td>
<td align="left" rowspan="2">Isotretinoin</td>
<td align="left" rowspan="2">20</td>
<td align="left" rowspan="2">Folds, mild elsewhere</td>
<td align="center" rowspan="2">No</td>
<td align="center" rowspan="2">Itch</td>
<td align="left" rowspan="2">Heat, stress, sun</td>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
</tr>
<tr>
<td align="left" rowspan="2">23<xref ref-type="table-fn" rid="t002fn001">*</xref></td>
<td align="left" rowspan="2">F</td>
<td align="left">c.1720G&gt;T</td>
<td align="left" rowspan="2">Isotretinoin</td>
<td align="left" rowspan="2">25</td>
<td align="left" rowspan="2">Trunk</td>
<td align="center" rowspan="2">No</td>
<td align="center" rowspan="2">Itch</td>
<td align="left" rowspan="2">Heat, stress, sun</td>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
</tr>
<tr>
<td align="left" rowspan="2">24</td>
<td align="left" rowspan="2">F</td>
<td align="left">c.116A&gt;G</td>
<td align="left" rowspan="2">Topical</td>
<td align="left" rowspan="2">1</td>
<td align="left" rowspan="2">Face, genital area, hands</td>
<td align="center" rowspan="2">Yes</td>
<td align="center" rowspan="2">Itch, odour, pain</td>
<td align="left" rowspan="2">Menstruation, stress</td>
</tr>
<tr>
<td align="left">c.220-18G&gt;A</td>
</tr>
<tr>
<td align="left">25</td>
<td align="left">M</td>
<td align="left"/>
<td align="left">Acitretin</td>
<td align="left">38</td>
<td align="left">Face, scalp, trunk, only mildly in skin folds</td>
<td align="center">Yes</td>
<td align="center">Itch</td>
<td align="left">Friction, stress, sun</td>
</tr>
<tr>
<td align="left">26<xref ref-type="table-fn" rid="t002fn001"><sup>††</sup></xref></td>
<td align="left">F</td>
<td align="left">c.2272C&gt;T</td>
<td align="left">Topical</td>
<td align="left">2</td>
<td align="left">Trunk, only mildly in skin folds, mild elsewhere</td>
<td align="center">Yes</td>
<td align="center">Itch, odour</td>
<td align="left">Heat, sun</td>
</tr>
<tr>
<td align="left" rowspan="2">27<xref ref-type="table-fn" rid="t002fn001"><sup>††</sup></xref></td>
<td align="left" rowspan="2">M</td>
<td align="left">c.2272C&gt;T</td>
<td align="left" rowspan="2"/>
<td align="left" rowspan="2"/>
<td align="left" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="center" rowspan="2"/>
<td align="left" rowspan="2"/>
</tr>
<tr>
<td align="left">c.2172G&gt;A</td>
</tr>
<tr>
<td align="left">28</td>
<td align="left">M</td>
<td align="left"/>
<td align="left">Topical</td>
<td align="left">10</td>
<td align="left">Scalp, trunk, only mildly in skin folds</td>
<td align="center">Yes</td>
<td align="center">Itch, pain</td>
<td align="left">Friction, heat, friction, stress</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t002fn001"><p>*<sup>, †,</sup> **<sup>, ††</sup> represent patients that are related. Rows that are blank are patients who did not harbour an <italic>ATP2A2</italic> variant or they did not answer the questionnaire. TBSA, total body surface area; F, female; M, male; Het, heterozygous; Hom, homozygous; i<italic>x</italic>, intron <italic>x</italic>; M<italic>x</italic>, transmembrane domain <italic>x</italic>; A, actuator domain; P, phosphorylation domain; N, nucleotide binding domain.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Patients were asked to score the medication effect and disease severity (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref> and <xref ref-type="supplementary-material" rid="pone.0186356.s002">S2 Fig</xref>). Disease severity was scored in two different ways: whether disease was mild, moderate or severe; and ranked from 1–5 (1 corresponding to bad and 5 to excellent). Both medication effect and disease severity were analysed based on the <italic>ATP2A2</italic> variant and the protein domain location (<xref ref-type="supplementary-material" rid="pone.0186356.s002">S2 Fig</xref>), and the type of mutation (i.e. missense, frameshift, etc.; <xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>).</p>
<fig id="pone.0186356.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pone.0186356.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Medication effect (1–5), disease severity (mild–severe) and disease severity (1–5) scores sorted by mutation type.</title>
<p>Medication effect and disease severity score (Top and bottom), a score of 1 = bad, 2 = acceptable, 3 = good, 4 = very good or 5 = excellent. Disease severity rate (Middle), a score of 1 = severe, 2 = moderate and 3 = mild. A score of 0 corresponds to patient’s lack of answer to a particular category. The type of <italic>ATP2A2</italic> mutation is shown on the x-axis, and they are sorted into seven categories: No mutations, benign, missense, in-frame deletion, splice-site, frameshift and nonsense mutations. ● represent patients receiving systemic treatment; ▲represents patients receiving topical treatment; ◆ represent patients receiving no treatment and <inline-formula id="pone.0186356.e001"><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0186356.e001" xlink:type="simple"/></inline-formula> represent patients who have received laser treatment. The different coloured points represent the patients with two <italic>ATP2A2</italic> variants. Points with the same colours are variants in the same patient.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.g003" xlink:type="simple"/>
</fig>
<p>Patients treated systemically were more satisfied with medication effect (good to excellent scores) than topically treated patients, who scored their medication effect as bad to good (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref> and <xref ref-type="supplementary-material" rid="pone.0186356.s002">S2 Fig</xref>–top graphs). Genotype-negative patients scored their medication effects as bad to good, while benign variants scored medication effect as generally good (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>, top graph). Medication effect for patients harbouring missense mutations were acceptable to very good regardless of treatment type (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>, top graph). All patients with in-frame deletion, splice site, frameshift and nonsense mutations were systemically treated and ranked the medication effect at good to excellent (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>, top graph).</p>
<p>The disease severity of genotype-negative patients or those with benign <italic>ATP2A2</italic> variants were rated as moderate (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>, middle graph). Many patients scored disease severity at 2 (using the 1–5 scoring system), which equated to acceptable (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>, bottom graph). Missense and in-frame deletion mutations caused mild to moderate disease, which is similar to the scores of 2 to 3 (acceptable to good) in disease severity (<xref ref-type="fig" rid="pone.0186356.g003">Fig 3</xref>, middle and bottom graphs). Splice-site and frameshift mutations scores were contradictory between the two different ranking systems. The scores varied widely for patients with either type of mutations (mild to severe); however, the corresponding disease severity scores ranged from 1 to 3 (bad to good).</p>
</sec>
</sec>
<sec id="sec012" sec-type="conclusions">
<title>Discussion</title>
<p>To date, no study has successfully correlated genotype to phenotype in DD. In the current study, we screened a Swedish cohort of 28 clinically diagnosed DD patients using WES and found 15 novel variants that have not been reported previously. We estimate that this cohort comprises more than 10% of DD patients in Sweden. Genotype-phenotype correlation was investigated based on disease severity scores and failed to show mutations with specific clinical picture.</p>
<sec id="sec013">
<title>Genotypic results</title>
<p>Twenty-one <italic>ATP2A2</italic> variants were identified in this study, 15 are novel variants that have not been previously reported. Sixteen of these variants are predicted to be pathogenic by <italic>in silico</italic> prediction programs. Despite the lack of functional studies investigating these variants, previous studies of different <italic>ATP2A2</italic> mutants (missense, nonsense and deletion mutations) showed that they all affect SERCA2 function by either decreasing protein expression, Ca<sup>2+</sup>-ATPase activity, Ca<sup>2+</sup> transport or alter protein kinetic properties [<xref ref-type="bibr" rid="pone.0186356.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0186356.ref014">14</xref>]. There is also evidence that mutant SERCA2 protein is an initiator of ER stress that causes human epidermal keratinocytes to round up, detach and induce apoptosis [<xref ref-type="bibr" rid="pone.0186356.ref010">10</xref>]. From these previous studies, it could be concluded that the 16 pathogenic variants reported in this study are likely to affect SRECA2 protein function. The variants are also associated with clinical data.</p>
<p>There were ten patients who had two <italic>ATP2A2</italic> variants (one double pathogenic and one double benign variants). To the authors’ best knowledge there has been no reported cases of patients harbouring two <italic>ATP2A2</italic> variants. Therefore, it is unknown whether the patient with two pathogenic variants have an additive effect on disease severity.</p>
<p>The four patients (14%) who are genotype-negative, but show skin symptoms could be wrongly diagnosed for DD. The number of genotype-negative patients in this study is similar to other reports in literature, which have a range of 7–33% of patients who are genotype-negative [<xref ref-type="bibr" rid="pone.0186356.ref008">8</xref>, <xref ref-type="bibr" rid="pone.0186356.ref033">33</xref>–<xref ref-type="bibr" rid="pone.0186356.ref035">35</xref>]. Three of the four patients have rated their disease as moderately severe. The fact that no <italic>ATP2A2</italic> variants were detected by WES does not necessarily mean that there is no mutation in the gene. There could be large deletions/insertions or cryptic splice-sites present that could not be detected using WES and require other methods (i.e. comparative genomic hybridisation microarray–CGH arrays, or multiplex ligation-dependent probe amplification–MLPA) to detect the copy number changes. There is also the possibility that some variants are in the unscreened regions of the <italic>ATP2A2</italic> gene, such as the promoter regions, intronic regions or the 3’ untranslated region, which could affect expression/or function of the SERCA2 protein.</p>
</sec>
<sec id="sec014">
<title>Phenotypic/clinical results</title>
<p>The clinical features/symptoms of the current cohort are similar to previously described DD patients [<xref ref-type="bibr" rid="pone.0186356.ref002">2</xref>, <xref ref-type="bibr" rid="pone.0186356.ref036">36</xref>], including age of onset, affected skin areas, skin symptoms and factors that exacerbate disease. The patients in this study are treated with either oral retinoids (acitretin or isotretinoin) or topical treatments, which are also typical for other DD patients [<xref ref-type="bibr" rid="pone.0186356.ref036">36</xref>]. Many patients have ranked the systemic treatment as effective against DD symptoms; however, the treatment is often not well tolerated and cannot be taken long term [<xref ref-type="bibr" rid="pone.0186356.ref002">2</xref>]. Like other reported DD cases, disease severity is varied [<xref ref-type="bibr" rid="pone.0186356.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0186356.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0186356.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0186356.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0186356.ref037">37</xref>–<xref ref-type="bibr" rid="pone.0186356.ref039">39</xref>]. Four patients in the current cohort ranked their disease as severe (16%), 18 as moderate (72%) and three as mild (12%, based on the disease severity rating results).</p>
</sec>
<sec id="sec015">
<title>Genotype-phenotype correlation</title>
<p>Similar to previous reports, establishing a cross-sectional genotype-phenotype correlation for DD was difficult [<xref ref-type="bibr" rid="pone.0186356.ref003">3</xref>, <xref ref-type="bibr" rid="pone.0186356.ref019">19</xref>, <xref ref-type="bibr" rid="pone.0186356.ref032">32</xref>, <xref ref-type="bibr" rid="pone.0186356.ref035">35</xref>, <xref ref-type="bibr" rid="pone.0186356.ref037">37</xref>–<xref ref-type="bibr" rid="pone.0186356.ref039">39</xref>]. Previous reports have shown that family members harbouring the same variant manifest different phenotypes [<xref ref-type="bibr" rid="pone.0186356.ref003">3</xref>], which was seen in the current study. Even when the <italic>ATP2A2</italic> variants were separated into protein region and mutation type (i.e. benign, missense, etc.), it was still difficult to find a correlation between genotype and phenotype. One possible reason could be that for a majority of <italic>ATP2A2</italic> variants, SERCA2 protein function is affected independent of the type or location of the mutation [<xref ref-type="bibr" rid="pone.0186356.ref009">9</xref>–<xref ref-type="bibr" rid="pone.0186356.ref014">14</xref>]. It could also be due to the variability of disease symptoms over time, which is influenced by environmental factors.</p>
<p>It is interesting to note that patients with only benign variants have moderate DD symptoms. Whether these variants have an effect on SERCA2 protein function is unknown, as none have been characterised. It is also possible that these patients could be DD phenocopies (non-genetic forms of the disease); however, Berg and Basset (1993) suggest the likelihood of this is rare [<xref ref-type="bibr" rid="pone.0186356.ref040">40</xref>]. This is because DD is a rare disease that is clearly inherited in an autosomal dominant manner [<xref ref-type="bibr" rid="pone.0186356.ref040">40</xref>]. There is also the possibility that the patients could harbour a second undetected <italic>ATP2A2</italic> variant (i.e. large deletion/insertion).</p>
</sec>
<sec id="sec016">
<title>Limitations</title>
<p>Currently, DD is diagnosed by its appearance and histopathology. There are some dermatological diseases that may also resemble DD. We believe that this “crude” non-molecular diagnostic method will be supported with genetic testing in the future to further confirm the clinical diagnosis. As well as analytical limitations that may not be detecting all DD variants, patients may be wrongly diagnosed with DD as their symptoms resemble DD, which confounds result interpretation. Other limitations of the study is that patients determined the medication efficacy and disease severity, and there will be variability in how these two factors were determined between patients. As the study only examined cross-sectional disease severity a longer and larger multicentre prospective study to investigate disease severity may be a better method of determining this factor.</p>
</sec>
</sec>
<sec id="sec017" sec-type="conclusions">
<title>Conclusion</title>
<p>Despite being unable to establish a genotype-phenotype correlation as the disease severity is variable amongst patients, we identified 15 novel variants that have not been previously reported in DD. This study is the first to use WES to screen DD patients, and it is the first to investigate the genetic aspect in Swedish DD patients.</p>
</sec>
<sec id="sec018">
<title>Supporting information</title>
<supplementary-material id="pone.0186356.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>The read-depth of all <italic>ATP2A2</italic> exons from all patient samples.</title>
<p>An x represents each patient sample and yellow circles represent patients who are genotype-negative. The red bars show the median and 95% confidence intervals.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0186356.s002" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.s002" xlink:type="simple">
<label>S2 Fig</label>
<caption>
<title>The scores patients gave for medication effect (1–5), disease severity (mild–severe) and disease severity (1–5) sorted by protein regions.</title>
<p>Medication effect and disease severity score (Top and bottom), a score of 1 = bad, 2 = acceptable, 3 = good, 4 = very good or 5 = excellent. Disease severity rate (Middle), a score of 1 = severe, 2 = moderate and 3 = mild. A score of 0 corresponds to patient’s lack of answer to a particular category. The type of <italic>ATP2A2</italic> mutation is shown on the x-axis, and they are sorted into protein domains. ● represent patients receiving systemic treatment; ▲ represents patients receiving topical treatment; ◆ represent patients receiving no treatment and <inline-formula id="pone.0186356.e002"><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0186356.e002" xlink:type="simple"/></inline-formula> represent patients who have received laser treatment.</p>
<p>(TIF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0186356.s003" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.s003" xlink:type="simple">
<label>S1 Table</label>
<caption>
<title>Polyphen-2, SNPs&amp;GO and SIFT predictions for novel missense variants found in this study.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pone.0186356.s004" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pone.0186356.s004" xlink:type="simple">
<label>S2 Table</label>
<caption>
<title>ASSP and Human Splicing Finder predictions for novel variants affecting splice sites found in this study.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank the families for kindly consenting to be part of this study and permitting this report. Further, we thank clinical research nurses Helena Griehsel, Papely Kassiri and Kristina Skoglund for excellent assistance. Finally, we express our gratitude to Prof. Mona Ståhle for senior mentorship.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pone.0186356.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tavadia</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Mortimer</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Munro</surname> <given-names>CS</given-names></name>. <article-title>Genetic epidemiology of Darier’s disease: A population study in the west of Scotland</article-title>. <source>British Journal of Dermatology</source>. <year>2002</year>;<volume>146</volume>:<fpage>107</fpage>–<lpage>109</lpage>. <object-id pub-id-type="pmid">11841374</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Burge</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Wilkinson</surname> <given-names>JD</given-names></name>. <article-title>Darier-White disease: A review of the clinical features in 163 patients</article-title>. <source>Journal of the American Academy of Dermatology</source>. <year>1992</year>;<volume>27</volume>:<fpage>40</fpage>–<lpage>50</lpage>. <object-id pub-id-type="pmid">1619075</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ruiz-Perez</surname> <given-names>VL</given-names></name>, <name name-style="western"><surname>Carter</surname> <given-names>SA</given-names></name>, <name name-style="western"><surname>Healy</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Todd</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Rees</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Steijlen</surname> <given-names>PM</given-names></name>, <etal>et al</etal>. <article-title><italic>ATP2A2</italic> mutations in Darier’s and disease: Variant and cutaneous phenotypes are associated with missense and mutations and but neuropsychiatric features are and independent of mutation class</article-title>. <source>Human Molecular Genetics</source>. <year>1999</year>;<volume>8</volume>:<fpage>1621</fpage>–<lpage>1630</lpage>. <object-id pub-id-type="pmid">10441324</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Foggia</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Hovnanian</surname> <given-names>A</given-names></name>. <article-title>Calcium pump disorders of the skin</article-title>. <source>American Journal of Medical Genetics Part C, Seminars in Medical Genetics</source>. <year>2004</year>;<volume>131C</volume>:<fpage>20</fpage>–<lpage>31</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ajmg.c.30031" xlink:type="simple">10.1002/ajmg.c.30031</ext-link></comment> <object-id pub-id-type="pmid">15468148</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jacobsen</surname> <given-names>NJ</given-names></name>, <name name-style="western"><surname>Lyons</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Hoogendoorn</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Burge</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kwok</surname> <given-names>PY</given-names></name>, <name name-style="western"><surname>O’Donovan</surname> <given-names>MC</given-names></name>, <etal>et al</etal>. <article-title><italic>ATP2A2</italic> mutations in Darier’s disease and their relationship to neuropsychiatric phenotypes</article-title>. <source>Human Molecular Genetics</source>. <year>1999</year>;<volume>8</volume>:<fpage>1631</fpage>–<lpage>1636</lpage>. <object-id pub-id-type="pmid">10441325</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakuntabhai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ruiz-Perez</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Carter</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jacobsen</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Burge</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Monk</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Mutations in <italic>ATP2A2</italic>, encoding a Ca<sup>2+</sup> pump, cause Darier disease</article-title>. <source>Nature Genetics</source>. <year>1999</year>;<volume>21</volume>:<fpage>271</fpage>–<lpage>277</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/6784" xlink:type="simple">10.1038/6784</ext-link></comment> <object-id pub-id-type="pmid">10080178</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fokkema</surname> <given-names>IF</given-names></name>, <name name-style="western"><surname>Taschner</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Schaafsma</surname> <given-names>GC</given-names></name>, <name name-style="western"><surname>Celli</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Laros</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>den Dunnen</surname> <given-names>JT</given-names></name>. <article-title>LOVD v.2.0: The next generation in gene variant databases</article-title>. <source>Human Mutation</source>. <year>2011</year>;<volume>32</volume>:<fpage>557</fpage>–<lpage>563</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.21438" xlink:type="simple">10.1002/humu.21438</ext-link></comment> <object-id pub-id-type="pmid">21520333</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nellen</surname> <given-names>RG</given-names></name>, <name name-style="western"><surname>Steijlen</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>van Steensel</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Vreeburg</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Frank</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>van Geel</surname> <given-names>M</given-names></name>. <article-title>Mendelian disorders of cornification caused by defects in intracellular calcium pumps: Mutation update and database for variants in ATP2A2 and ATP2C1 associated with Darier disease and Hailey-Hailey disease</article-title>. <source>Human Mutation</source>. <year>2017</year>;<volume>38</volume>:<fpage>343</fpage>–<lpage>356</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/humu.23164" xlink:type="simple">10.1002/humu.23164</ext-link></comment> <object-id pub-id-type="pmid">28035777</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ahn</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>MG</given-names></name>, <name name-style="western"><surname>Kim</surname> <given-names>KH</given-names></name>, <name name-style="western"><surname>Muallem</surname> <given-names>S</given-names></name>. <article-title>Multiple effects of SERCA2b mutations associated with Darier’s disease</article-title>. <source>Journal of Biological Chemistry</source>. <year>2003</year>;<volume>278</volume>:<fpage>20795</fpage>–<lpage>20801</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M301638200" xlink:type="simple">10.1074/jbc.M301638200</ext-link></comment> <object-id pub-id-type="pmid">12670936</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Bruce</surname> <given-names>AT</given-names></name>, <name name-style="western"><surname>Tu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ma</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Zeng</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Zheng</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>Protein aggregation of SERCA2 mutants associated with Darier disease elicits ER stress and apoptosis in keratinocytes</article-title>. <source>Journal of Cell Science</source>. <year>2011</year>;<volume>124</volume>:<fpage>3568</fpage>–<lpage>3580</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1242/jcs.084053" xlink:type="simple">10.1242/jcs.084053</ext-link></comment> <object-id pub-id-type="pmid">22045735</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dode</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>JP</given-names></name>, <name name-style="western"><surname>Leslie</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Dhitavat</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Vilsen</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Hovnanian</surname> <given-names>A</given-names></name>. <article-title>Dissection of the functional differences between sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase (SERCA) 1 and 2 isoforms and characterization of Darier disease (SERCA2) mutants by steady-state and transient kinetic analyses</article-title>. <source>Journal of Biological Chemistry</source>. <year>2003</year>;<volume>278</volume>:<fpage>47877</fpage>–<lpage>47889</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M306784200" xlink:type="simple">10.1074/jbc.M306784200</ext-link></comment> <object-id pub-id-type="pmid">12975374</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sato</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Yamasaki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Daiho</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Miyauchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ishida-Yamamoto</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Distinct types of abnormality in kinetic properties of three Darier disease-causing sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase mutants that exhibit normal expression and high Ca<sup>2+</sup> transport activity</article-title>. <source>Journal of Biological Chemistry</source>. <year>2004</year>;<volume>279</volume>:<fpage>35595</fpage>–<lpage>3560</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.M404887200" xlink:type="simple">10.1074/jbc.M404887200</ext-link></comment> <object-id pub-id-type="pmid">15208303</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miyauchi</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Daiho</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Yamasaki</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Takahashi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ishida-Yamamoto</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Danko</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Comprehensive analysis of expression and function of 51 sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase mutants associated with Darier disease</article-title>. <source>Journal of Biological Chemistry</source>. <year>2006</year>;<volume>281</volume>:<fpage>2282</fpage>–<lpage>22895</lpage>.</mixed-citation></ref>
<ref id="pone.0186356.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leinonen</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Myllyla</surname> <given-names>RM</given-names></name>, <name name-style="western"><surname>Hagg</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Tuukkanen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Koivunen</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Peltonen</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Keratinocytes cultured from patients with Hailey-Hailey disease and Darier disease display distinct patterns of calcium regulation</article-title>. <source>British Journal of Dermatology</source>. <year>2005</year>;<volume>153</volume>:<fpage>113</fpage>–<lpage>117</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1365-2133.2005.06623.x" xlink:type="simple">10.1111/j.1365-2133.2005.06623.x</ext-link></comment> <object-id pub-id-type="pmid">16029335</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leinonen</surname> <given-names>PT</given-names></name>, <name name-style="western"><surname>Hagg</surname> <given-names>PM</given-names></name>, <name name-style="western"><surname>Peltonen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jouhilahti</surname> <given-names>EM</given-names></name>, <name name-style="western"><surname>Melkko</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Korkiamaki</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Reevaluation of the normal epidermal calcium gradient, and analysis of calcium levels and ATP receptors in Hailey-Hailey and Darier epidermis</article-title>. <source>Journal of Investigative Dermatology</source>. <year>2009</year>;<volume>129</volume>:<fpage>1379</fpage>–<lpage>1387</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/jid.2008.381" xlink:type="simple">10.1038/jid.2008.381</ext-link></comment> <object-id pub-id-type="pmid">19052563</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cederlof</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Karlsson</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Larsson</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Almqvist</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Magnusson</surname> <given-names>PK</given-names></name>, <name name-style="western"><surname>Nordlind</surname> <given-names>K</given-names></name>, <etal>et al</etal>. <article-title>Intellectual disability and cognitive ability in Darier disease: Swedish nation-wide study</article-title>. <source>British Journal of Dermatology</source>. <year>2015</year>;<volume>173</volume>:<fpage>155</fpage>–<lpage>158</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bjd.13740" xlink:type="simple">10.1111/bjd.13740</ext-link></comment> <object-id pub-id-type="pmid">25704118</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Di Palo</surname> <given-names>M</given-names></name>. <article-title>Rating satisfaction research: Is it poor, fair, good, very good, or excellent?</article-title> <source>Arthritis Care and Research</source>. <year>1997</year>;<volume>10</volume>:<fpage>422</fpage>–<lpage>430</lpage>. <object-id pub-id-type="pmid">9481234</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Knaysi</surname> <given-names>GA</given-names></name>, <name name-style="western"><surname>Crikelair</surname> <given-names>GF</given-names></name>, <name name-style="western"><surname>Cosman</surname> <given-names>B</given-names></name>. <article-title>The role of nines: Its history and accuracy</article-title>. <source>Plastic and Reconstructive Surgery</source>. <year>1968</year>;<volume>41</volume>:<fpage>560</fpage>–<lpage>563</lpage>. <object-id pub-id-type="pmid">5654897</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ringpfeil</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Raus</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>DiGiovanna</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Korge</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Harth</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Mazzanti</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Darier disease–novel mutations in ATP2A2 and genotype–phenotype correlation</article-title>. <source>Experimental Dermatology</source>. <year>2001</year>;<volume>10</volume>:<fpage>19</fpage>–<lpage>27</lpage>. <object-id pub-id-type="pmid">11168576</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leong</surname> <given-names>IUS</given-names></name>, <name name-style="western"><surname>Dryland</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Prosser</surname> <given-names>DO</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Graham</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Stiles</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Splice Site Variants in the <italic>KCNQ1</italic> and <italic>SCN5A</italic> Genes: Transcript Analysis as a Tool in Supporting Pathogenicity</article-title>. <source>Journal of Clinical Medicine Research</source>. <year>2017</year>;<volume>9</volume>:<fpage>709</fpage>–<lpage>718</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.14740/jocmr2894w" xlink:type="simple">10.14740/jocmr2894w</ext-link></comment> <object-id pub-id-type="pmid">28725320</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kearse</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Moir</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Wilson</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Stones-Havas</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Cheung</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sturrock</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data</article-title>. <source>Bioinformatics</source>. <year>2012</year>;<volume>28</volume>:<fpage>1647</fpage>–<lpage>1649</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/bioinformatics/bts199" xlink:type="simple">10.1093/bioinformatics/bts199</ext-link></comment> <object-id pub-id-type="pmid">22543367</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adzhubei</surname> <given-names>IA</given-names></name>, <name name-style="western"><surname>Schmidt</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Peshkin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Ramensky</surname> <given-names>VE</given-names></name>, <name name-style="western"><surname>Gerasimova</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bork</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <article-title>A method and server for predicting damaging missense mutations</article-title>. <source>Nature Methods</source>. <year>2010</year>;<volume>7</volume>:<fpage>248</fpage>–<lpage>249</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nmeth0410-248" xlink:type="simple">10.1038/nmeth0410-248</ext-link></comment> <object-id pub-id-type="pmid">20354512</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sim</surname> <given-names>NL</given-names></name>, <name name-style="western"><surname>Kumar</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Henikoff</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Schneider</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Ng</surname> <given-names>PC</given-names></name>. <article-title>SIFT web server: Predicting effects of amino acid substitutions on proteins</article-title>. <source>Nucleic Acids Research</source>. <year>2012</year>;<volume>40</volume>:<fpage>W452</fpage>–<lpage>457</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gks539" xlink:type="simple">10.1093/nar/gks539</ext-link></comment> <object-id pub-id-type="pmid">22689647</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Capriotti</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Calabrese</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Fariselli</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Martelli</surname> <given-names>PL</given-names></name>, <name name-style="western"><surname>Altman</surname> <given-names>RB</given-names></name>, <name name-style="western"><surname>Casadio</surname> <given-names>R</given-names></name>. <article-title>WS-SNPs&amp;GO: A web server for predicting the deleterious effect of human protein variants using functional annotation</article-title>. <source>BMC Genomics</source>. <year>2013</year>;<volume>14</volume> <issue>Suppl 3</issue>:<fpage>S6</fpage>.</mixed-citation></ref>
<ref id="pone.0186356.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Marin</surname> <given-names>A</given-names></name>. <article-title>Characterization and prediction of alternative splice sites</article-title>. <source>Gene</source>. <year>2006</year>;<volume>366</volume>:<fpage>219</fpage>–<lpage>227</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.gene.2005.07.015" xlink:type="simple">10.1016/j.gene.2005.07.015</ext-link></comment> <object-id pub-id-type="pmid">16226402</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Desmet</surname> <given-names>FO</given-names></name>, <name name-style="western"><surname>Hamroun</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Lalande</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Collod-Beroud</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Claustres</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Beroud</surname> <given-names>C</given-names></name>. <article-title>Human Splicing Finder: A n online bioinformatics tool to predict splicing signals</article-title>. <source>Nucleic Acids Research</source>. <year>2009</year>;<volume>37</volume>:<fpage>e67</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkp215" xlink:type="simple">10.1093/nar/gkp215</ext-link></comment> <object-id pub-id-type="pmid">19339519</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leong</surname> <given-names>IU</given-names></name>, <name name-style="western"><surname>Stuckey</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lai</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Skinner</surname> <given-names>JR</given-names></name>, <name name-style="western"><surname>Love</surname> <given-names>DR</given-names></name>. <article-title>Assessment of the predictive accuracy of five in silico prediction tools, alone or in combination, and two metaservers to classify long QT syndrome gene mutations</article-title>. <source>BMC Medical Genetics</source>. <year>2015</year>;<volume>16</volume>:<fpage>34</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s12881-015-0176-z" xlink:type="simple">10.1186/s12881-015-0176-z</ext-link></comment> <object-id pub-id-type="pmid">25967940</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sherry</surname> <given-names>ST</given-names></name>, <name name-style="western"><surname>Ward</surname> <given-names>MH</given-names></name>, <name name-style="western"><surname>Kholodov</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Baker</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Phan</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Smigielski</surname> <given-names>EM</given-names></name>, <etal>et al</etal>. <article-title>dbSNP: The NCBI database of genetic variation</article-title>. <source>Nucleic Acids Research</source>. <year>2001</year>;<volume>29</volume>:<fpage>308</fpage>–<lpage>311</lpage>. <object-id pub-id-type="pmid">11125122</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lek</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Karczewski</surname> <given-names>KJ</given-names></name>, <name name-style="western"><surname>Minikel</surname> <given-names>EV</given-names></name>, <name name-style="western"><surname>Samocha</surname> <given-names>KE</given-names></name>, <name name-style="western"><surname>Banks</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Fennell</surname> <given-names>T</given-names></name>, <etal>et al</etal>. <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source>. <year>2016</year>;<volume>536</volume>:<fpage>285</fpage>–<lpage>291</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature19057" xlink:type="simple">10.1038/nature19057</ext-link></comment> <object-id pub-id-type="pmid">27535533</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref030"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP). Seattle, WA;.<ext-link ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/" xlink:type="simple">http://evs.gs.washington.edu/EVS/</ext-link>.</mixed-citation></ref>
<ref id="pone.0186356.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kiec-Wilk</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Dembinska-Kiec</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Olszanecka</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Bodzioch</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Schmitz</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Kawecka-Jaszcz</surname> <given-names>K</given-names></name>. <article-title>A724A polymorphism of sarco(endo)plasmic reticulum Ca<sup>2+</sup>-ATPase 2 (SERCA2) in hypertensive patients</article-title>. <source>Clinical Chemistry and Laboratory Medicine</source>. <year>2007</year>;<volume>45</volume>:<fpage>467</fpage>–<lpage>470</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1515/CCLM.2007.092" xlink:type="simple">10.1515/CCLM.2007.092</ext-link></comment> <object-id pub-id-type="pmid">17439322</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Klausegger</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Nischler</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Wagner</surname> <given-names>RN</given-names></name>, <name name-style="western"><surname>Pletschacher</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Hintner</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bauer</surname> <given-names>JW</given-names></name>. <article-title>Seven novel mutations in the ATP2A2 gene of Austrian patients with Darier’s disease</article-title>. <source>Archives of Dermatological Research</source>. <year>2011</year>;<volume>303</volume>:<fpage>371</fpage>–<lpage>374</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00403-011-1148-6" xlink:type="simple">10.1007/s00403-011-1148-6</ext-link></comment> <object-id pub-id-type="pmid">21519848</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bchetnia</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Benmously</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ben Brick</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Charfeddine</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ben Ameur</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Fajraoui</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>New mutations of Darier disease in Tunisian patients</article-title>. <source>Archives of Dermatological Research</source>. <year>2009</year>;<volume>301</volume>:<fpage>615</fpage>–<lpage>619</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00403-009-0963-5" xlink:type="simple">10.1007/s00403-009-0963-5</ext-link></comment> <object-id pub-id-type="pmid">19488774</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dodiuk-Gad</surname> <given-names>RP</given-names></name>, <name name-style="western"><surname>Cohen-Barak</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Khayat</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Milo</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Amariglio-Diskin</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Danial-Faran</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Darier disease in Israel: Combined evaluation of genetic and neuropsychiatric aspects</article-title>. <source>British Journal of Dermatology</source>. <year>2015</year>;<volume>174</volume>:<fpage>562</fpage>–<lpage>568</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bjd.14220" xlink:type="simple">10.1111/bjd.14220</ext-link></comment> <object-id pub-id-type="pmid">26471493</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakuntabhai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Burge</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Monk</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hovnanian</surname> <given-names>A</given-names></name>. <article-title>Spectrum of novel <italic>ATP2A2</italic> mutations in patients with Darier’s disease</article-title>. <source>Human Molecular Genetics</source>. <year>1999</year>;<volume>8</volume>:<fpage>1611</fpage>–<lpage>1619</lpage>. <object-id pub-id-type="pmid">10441323</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Takagi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Kamijo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Ikeda</surname> <given-names>S</given-names></name>. <article-title>Darier disease</article-title>. <source>The Journal of Dermatology</source>. <year>2016</year>;<volume>43</volume>:<fpage>275</fpage>–<lpage>279</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1346-8138.13230" xlink:type="simple">10.1111/1346-8138.13230</ext-link></comment> <object-id pub-id-type="pmid">26945535</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bchetnia</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Charfeddine</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Kassar</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Zribi</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Guettiti</surname> <given-names>HT</given-names></name>, <name name-style="western"><surname>Ellouze</surname> <given-names>F</given-names></name>, <etal>et al</etal>. <article-title>Clinical and mutational heterogeneity of Darier disease in Tunisian families</article-title>. <source>Archives of Dermatology</source>. <year>2009</year>;<volume>145</volume>:<fpage>654</fpage>–<lpage>656</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/archdermatol.2009.52" xlink:type="simple">10.1001/archdermatol.2009.52</ext-link></comment> <object-id pub-id-type="pmid">19528419</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Godic</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Strazisar</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Zupan</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Korosec</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Kansky</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Glavac</surname> <given-names>D</given-names></name>. <article-title>Darier disease in Slovenia: Spectrum of <italic>ATP2A2</italic> mutations and relation to patients’ phenotypes</article-title>. <source>European Journal of Dermatology</source>. <year>2010</year>;<volume>20</volume>:<fpage>271</fpage>–<lpage>275</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1684/ejd.2010.0913" xlink:type="simple">10.1684/ejd.2010.0913</ext-link></comment> <object-id pub-id-type="pmid">20423818</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Green</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Gordon-Smith</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Burge</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Grozeva</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Munro</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Tavadia</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Novel <italic>ATP2A2</italic> mutations in a large sample of individuals with Darier disease</article-title>. <source>The Journal of Dermatology</source>. <year>2013</year>;<volume>40</volume>:<fpage>259</fpage>–<lpage>266</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1346-8138.12082" xlink:type="simple">10.1111/1346-8138.12082</ext-link></comment> <object-id pub-id-type="pmid">23356892</object-id></mixed-citation></ref>
<ref id="pone.0186356.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berg</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Bassett</surname> <given-names>AS</given-names></name>. <article-title>Darier’s disease: Current understanding of pathogenesis and future role of genetic studies</article-title>. <source>International Journal of Dermatology</source>. <year>1993</year>;<volume>32</volume>:<fpage>397</fpage>–<lpage>400</lpage>. <object-id pub-id-type="pmid">8320017</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>